News & Events
LaVoieHealthScience Names James (Jim) Heins as Senior Vice President and Managing Director of its New York Practice
LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced the appointment of James (Jim) Heins as Senior Vice President and Managing Director of its New York practice, expanding the agency’s senior leadership team to seven members.
BOSTON AND NEW YORK - AUGUST 03, 2020 LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today...
BOSTON/NEW YORK/GRAINAU, GERMANY – June 22, 2020 — LaVoieHealthScience (“LHS”) and Bioscience Valuation BSV GmbH (“BSV”) today announced a strategic alliance between the two firms. The alliance...
Access the event and schedule of presenting companies at virtualinvestorsummit.com Live audio webcast presentations and interactive Q&A Company presentations will be held from 10 AM-12 PM ET and...
Our event calendar includes select industry, medical and investor conferences that LHS and clients will attend throughout the year.
LaVoieHealthScience President and CEO, Donna LaVoie, contributed to the O’Dwyer’s PR News Magazine October issue focused on healthcare and medical public relations.
With ESG investing moving from tipping point to turning point, what impact will the new DOL rules have on investors and plan sponsors? Given the macro-level upheavals that have taken place so far in...
Mike Gaito, Global Head of Healthcare Investment Banking at J.P. Morgan talks #JPM21 going virtual, IPOs, and broader market trends for the new year
As announced last month, the 39th Annual J.P. Morgan Healthcare Conference will be held virtually from January 11-14, 2021 – a first for the conference. The bank’s decision to move to a fully virtual format has created a ripple effect among other shoulder events organized around the week of the conference, often referred to simply as “JPM Week”.
The SARS-CoV-2 pathogen has scrambled literally everything around the world, including financial markets and the world economy. At the same time, the biotech and pharmaceutical industries are...
Partner with us to build your winning company
Our experienced, multi-disciplined team provides seamless integrated communications, offering strategy consulting, investor and corporate communications and public relations/marketing.